HemaSphere (Aug 2023)
PB2698: MORE EFFICIENT DELIVERY OF HIGH-COST STANDARD-OF-CARE THERAPIES IN RELAPSED MULTIPLE MYELOMA USING REAL-TIME FEEDBACK OF PATIENT-REPORTED OUTCOME MEASURES: THE MY-PROMPT-2 TRIAL
- Elizabeth Moore,
- Simon Harrison,
- P. Joy Ho,
- Adam Irving,
- Tracy King,
- Georgia Mccaughan,
- Zoe Mcquilten,
- Peter Mollee,
- Susanna Park,
- Dennis Petrie,
- John Reynolds,
- Claudia Rutherford,
- Tina van Tonder,
- Cameron Wellard,
- Erica Wood,
- Andrew Spencer
Affiliations
- Elizabeth Moore
- 1 Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia
- Simon Harrison
- 2 Peter MacCallum Cancer Centre, Melbourne, Australia
- P. Joy Ho
- 4 Royal Prince Alfred Hospital, Sydney, Australia
- Adam Irving
- 1 Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia
- Tracy King
- 4 Royal Prince Alfred Hospital, Sydney, Australia
- Georgia Mccaughan
- 7 St Vincent’s Hospital, Sydney, Australia
- Zoe Mcquilten
- 1 Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia
- Peter Mollee
- 8 Princess Alexandra Hospital, Brisbane, Australia
- Susanna Park
- 10 University of Sydney, School of Medical Sciences, Sydney, Australia
- Dennis Petrie
- 6 Monash University, Centre for Health Economics, Melbourne, Australia
- John Reynolds
- 11 The Alfred Hospital, Melbourne, Australia
- Claudia Rutherford
- 13 University of Sydney, Faculty Medicine and Health, Sydney, Australia
- Tina van Tonder
- 1 Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia
- Cameron Wellard
- 1 Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia
- Erica Wood
- 1 Monash University, School of Public Health and Preventive Medicine, Melbourne, Australia
- Andrew Spencer
- 11 The Alfred Hospital, Melbourne, Australia
- DOI
- https://doi.org/10.1097/01.HS9.0000977464.68933.f0
- Journal volume & issue
-
Vol. 7
p. e68933f0
Abstract
No abstracts available.